Kennedy Ferruggia, Assistant Editor

Diana Isaacs, PharmD, highlights evolving criteria for insulin pump therapy in type 2 diabetes.

Ginger Thorpe discusses how in-house specialty pharmacy models enhance patient care, streamline communication, and boost health system revenue amid rising demand.

Allegheny General Hospital enhances pharmacy operations through centralized, robotics-enabled IV compounding, boosting efficiency and patient care.

Prescriber incentives boost nicotine replacement therapy prescribing and enhance patient access to smoking cessation support in health care settings.

Pharmacy leaders navigate complex compliance challenges, budget constraints, and evolving technology to enhance safety and efficiency in compounding practices.

IV compounding robotics enhance safety, reduce drug shortages, and improve efficiency in hospital pharmacies, driving a shift towards automation.

Specialty pharmacy services are helping improve IBD care by supporting patient education, access, and confidence in biosimilars

Pharmacists play a vital role in preventing maternal and neonatal mortality by understanding pregnancy-specific medication needs and emergency care strategies.

Coffee Consumption May Reduce Depression Risk and Boost Mood, Offering Potential Benefits for Mental Health

The FDA approved durvalumab with FLOT chemotherapy, revolutionizing treatment for early gastric and gastroesophageal junction cancers, enhancing survival rates.

New research reveals how age, lifestyle, and diabetes alter the gluteus maximus shape, highlighting sex-specific responses and metabolic health implications.

The FDA approves ruxolitinib cream for treating atopic dermatitis in children, offering hope for millions affected by this chronic skin condition.

Discover the stages of migraines and explore innovative treatments like Symbravo, designed to alleviate pain and improve quality of life.

City-level COVID-19 vaccine mandates in the US have limited impact on vaccination rates and health outcomes.

Dexcom Smart Basal optimizes basal insulin dosing for type 2 diabetes, enhancing management with personalized recommendations and a 15-day CGM sensor.

FDA approves daratumumab and hyaluronidase for treating newly diagnosed light chain (AL) amyloidosis, enhancing survival rates and treatment efficacy.

Plozasiran gains FDA approval to significantly lower triglycerides in adults with familial chylomicronemia syndrome, enhancing heart health management.

FDA Approval Introduces a First-in-Class Neurokinin Receptor Agonist Shown to Reduce Vasomotor Symptom Frequency and Improve Sleep Quality in Postmenopausal Women

Researchers uncover key factors influencing glucose fluctuations in type 2 diabetes, highlighting the importance of continuous glucose monitoring for effective management.

New research shows that an increased consumption of ultraprocessed foods significantly raises prediabetes risk in young adults, highlighting urgent dietary intervention needs.

New research reveals similar severe outcomes for adults hospitalized with hMPV and RSV, emphasizing the need for awareness of both infections.

Semaglutide shows significant weight loss and reduces obesity-related health risks, offering a promising solution for effective weight management.

Inclisiran significantly enhances LDL-C goal attainment in post-acute coronary syndrome patients, improving lipid management outcomes.

Consistent use of continuous glucose monitoring (CGM) significantly improves glycemic control in adults with type 2 diabetes (T2D).

Maternal type 1 diabetes may influence children's DNA, potentially reducing their risk of developing islet autoimmunity.

The FDA approves daratumumab and hyaluronidase for high-risk smoldering multiple myeloma, significantly improving patient outcomes and progression-free survival.

Leukogene's M2T-CD33 gains FDA orphan drug status, promising a novel immunotherapy approach for acute myeloid leukemia treatment.

Discover the importance of early screening for type 1 diabetes and how it can prevent life-threatening complications.

Oral semaglutide shows promise in enhancing glucose control and reducing cardiovascular risks.

Shara Bialo, MD, emphasizes the critical role of autoantibody screening in early T1D detection, enhancing patient outcomes during American Diabetes Month.